Drug · DIN 02223066
FROBEN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 6, 2008; first marketed February 6, 1997.
- Drug Identification Number (DIN)
- 02223066
- Company (DIN owner)
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Flurbiprofen M01AE09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLURBIPROFEN | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 30, 2001: NOC 2269New Drug Submission (NDS) · Change in manufacturer's name
- June 18, 1996: NOC 4420New Drug Submission (NDS)
Other DINs named FROBEN
- DIN 02223074 · Cancelled Post Market